Janus Biotech India Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 5 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.85 Cr
About Janus Biotech India
Janus Biotech India Private Limited (JBIPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 May 2019 (Five years and eight months 25 days old ). Its registered office is in Chandigarh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹2.85 Cr.
Ravneet Singh, Harsimran Kalra, and Jitender Kalra serve as directors at the Company.
Company Details
- Location
Chandigarh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U51909CH2019PTC042503
- Company No.
042503
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 May 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
What products or services does Janus Biotech India Private Limited offer?
Janus Biotech India Private Limited offers a wide range of products and services, including Healthcare Products & Aids, Health Drinks, Hand Sanitizers & Personal Hygiene, Beauty Soap, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Common Disease Medicines, Anti Acne Drug, Cosmetics, Hair & Beauty Products, Skin Care Cosmetics.
Who are the key members and board of directors at Janus Biotech India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravneet Singh  | Director | 07-May-2019 | Current |
| Harsimran Kalra | Director | 07-May-2019 | Current |
| Jitender Kalra | Director | 23-Aug-2019 | Current |
Financial Performance of Janus Biotech India.
Janus Biotech India Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Janus Biotech India?
In 2020, Janus Biotech India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Systole Remedies Private LimitedRavneet Singh, Harsimran Kalra and 1 more are mutual person
Burgeon Health Series Private LimitedRavneet Singh, Harsimran Kalra and 1 more are mutual person
Nyx Pharmaceuticals Private LimitedRavneet Singh, Harsimran Kalra and 1 more are mutual person
- Flanca Life Sciences Private Limited
Ravneet Singh, Harsimran Kalra and 1 more are mutual person
Charges (Loans)
₹28.50 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 2.85 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Dec 2020 | Axis Bank Limited | ₹2.85 Cr | Open |
How Many Employees Work at Janus Biotech India?
Unlock and access historical data on people associated with Janus Biotech India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Janus Biotech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Janus Biotech India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.